Longeveron (LGVN) Selling, General & Administrative (2020 - 2026)
Longeveron (LGVN) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | 101.25 Mn |
| 10 | Longeveron | 15.19 Bn | 15.18 Bn | 264,000.00 | 2.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 3.52 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 3.26 Mn |